Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 50, 2021 - Issue 2-3
170
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Effect of H4R Antagonist N-(2-Aminoethyl)-5-Chloro-1H-Indole-2-Carboxamide (Compound A) in a Mouse Model of Allergic Asthma

&

References

  • Ahmad SF, Mushtaq AA, Zoheir KM, Bakheet SA, Korashy HM, Nadeem A, Ashour AE, Attia SM. 2015. Regulation of TNF-a and NFj-B activation through the JAK/STAT signalling pathway downstream of histamine 4 receptor in a rat model of LPS-induced joint inflammation. Immunobiology. 220:889–98.
  • Angel Jemima E, Prema A, Berla Thangam E. 2014. Functional characterisation of histamine H4 receptor on human mast cells. Mol Immunol. 62(1):19–28.
  • Annan N, Silverman RB. 1993. New analogues of N-(2-aminoethyl)-4-chlorobenzamide (Ro 16-6491). Some of the most potent monoamine oxidase-B inactivators. J Med Chem. 36(24):3968–70.
  • Audaloussi M, Lim HD, Van der Meer T, Sijm M, Poulie CBM, de Esch IJP, Leurs R, Smits RA. 2013. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787. Bioorg Med Chem Lett. 23(9):2663–70.
  • Beaumer W, Stahl J, Sander K, Petersen LJ, Paps J, Stark H, Kietzmann M, Olivry T. 2011. Lack of preventing effect of systemically and topically administered histamine H1 or H4 receptor antagonists in a dog model of acute atopic dermatitis. Exp Dermatol. 20(7):577–81.
  • Beerman SG, Glade S, Jonigk D, Seifert R, Neumann D. 2012. Opposite effects of mepramine on JNJ7777120- induced amelioration of experimentally induced asthma in mice in sensitization and provocation. PLoS One. 7(1):e30285.
  • Christopher F, Berla Thangam E, Xavier M. 2012. A bioinformatics search for selective histamine H4 receptor antagonists through structure-based virtual screening strategies. Chem Biol Drug Des. 79(5):749–59.
  • Coruzzi G, Adami M, Guaita E, Esch IJP, Leurs R. 2007. Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur J Pharmacol. 563(1–3):240–44.
  • Cowden JM, Riley JP, Ma JY, Thurmond RL, Dunford PJ. 2010. Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokine. Respir Res. 11(1):86.
  • David LB, Samuel ED, Cesar C, Chen D, Dunford PJ, Barchuk W, Firestein GS, Thurmond RL. 2019. Toreforant, an orally active histamine H4- receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double- blind, placebo- controlled synovial biopsy study. Inflamm Res. 68(4):261–74.
  • Desai P, Thurmond RL. 2011. Histamine H4 receptor activation enhances LPS-induced IL-6 production in mast cells via ERK and PI3K activation. Eur J Immunol. 41(6):1764–73.
  • Elsner J, Kapp A. 1999. Regulation and modulation of eosinophil effector functions. Allergy. 54:15–26.
  • Engelhardt H, de Esch IJP, Kuhn D, Smits RA, Zuiderveld OP, Dobler J, Mayer M, Lips S, Arnhof H, Scharn D, et al. 2012. Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands. Eur J Med Chem. 54:660–68.
  • Flohe L, Brigelius- Flohe R, Saliou C, Traber MG, Packer L. 1997. Redox regulation of NF-κB activation. Free Radic Biol Med. 22:1115–26.
  • Gutzmer R, Diestel C, Mommerts S, Köther B, Stark H, Wittmann M, Werfel T. 2005. Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte- derived dendritic cells. J Immunol. 174(9):5224–32.
  • Gutzmer R, Mommert S, Gschwandtner M, Zwingmann K, Stark H, Werfel T. 2009. The histamine H4 receptor is functionally expressed on T(H)2 cells. J Allergy Clin Immunol. 123(3):619–25.
  • Hall S, Agrawal DK. 2014. Key mediators in the immunopathogenesis of allergic asthma. Int Immunopharmacol. 23(1):316–29.
  • Jablonowski JA, Grice CA, Chai W, Dvorak CA, Venable JD, Kwok AK, Ly KS, Wei J, Baker SM, Desai PJ, et al. 2003. The first potent and selective non-imidazole human histamine h4 receptor antagonists. J Med Chem. 46(19):3957–60.
  • Janeway CA Jr, Travers P, Walport M, Shlomchik MJ. 2001. The immune system in health and disease. Immunobiol. 5th ed. New York: Garland Science.
  • Li X, Chen Q, Chu C, You H, Jin M, Zhao X, Zhu X, Zhou W, Ji W. 2014. Ovalbumin- induced experimental allergic asthma is Toll-like receptor 2 dependent. Allergy Asthma Proc. 35(2):e15–20.
  • Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R. 2005. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther. 314(3):1310–21.
  • Lorentz A, Klopp I, Gebhdt T, Manns MP, Bischoff SC. 2003. Role of activator protein 1, nuclear factor- kappa B, and nuclear factor of activated T cells in IgE receptor- mediated cytokine expression in mature human mast cells. J Allergy Clin Immunol. 111:1062–68.
  • Masoli, Fabian, Holt, Beasley. 2004. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy. 59(5):469–78.
  • Nagarajan G, Mariappanadar V, Tamizh M, Kaliappan I, Elden BT. 2016. Effect of H4R antagonist N-(2-aminoethyl)-5-chloro-1H-indol-2-carboxamides and 5-chloro-2-(piperazin-1-ylmethyl)-1H-benzimidazole on histamine and 4-methylhistamine- induced mast cell response. J Recept Signal Transduction. doi:10.1080/10799893.2016.1247863
  • Engel M, Fröhner W, Stroba A,  Biondi RM. 2010. Preparation of 4-heterocyclyl-3-arylbutanoic acid, 3,4-diarylbutanoic acid, 4-heterocyclyl-3-aryl-2-pentenoic acid, and 3,5-diaryl-2-pentenoic acid derivatives as allosteric protein kinase modulators. PCT Int Appl. 2010043711.
  • Panettieri RA JR. 2003. Airway smooth muscle: immunomodulatory cells that modulate airway remodelling? Respir Physiol Neurobiol. 137:277–93.
  • Pelaia G, Cuda G, Vatrella A, Gallelli I, Caraglia M, Marra M, Abbruzzese A, Caputi M, Maselli R, Costanzo FS, et al. 2005. Mitogen activated protein kinases and asthma. J Cell Physol. 202:642–53.
  • Reher TM, Neumann D, Buschauer A, Seifer R. 2012. Incomplete activation of human eosinophils via the histamine H4-receptor; evidence for ligand-specific receptor conformations. Biochem Pharmacol. 84:192–203.
  • Remko AB, Schoonus SBJ, Smit MJ, Timmerman H, Leurs R. 2001. Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signalling. Mol Pharmacol. 60:1133–42.
  • Rossbach K, Wendorff S, Sander K, Stark H, Gutzmer R, Werfel T, Kietzmann M, Bäumer W. 2009. Histamine H4 receptor antagonism reduces hapten- induced scratching behaviour but not inflammation. Exp Dermatol. 18(1):57–63.
  • Schroeder JT, Macglashan DW Jr, Lichtenstein LM. 2001. Human basophils: mediator release and cytokine production. Adv Immunol. 77:93–122.
  • Seifert R, Schneider EH, Dove S, Brunskole I, Neumann D, Strasser A, Buschauer A. 2011. Pardoxical stimulatory effect of the standard histamine H4 receptor antagonist JNJ7777120: the H4 receptor joins the club of 7 transmembrane domine receptors exhibiting functional selectivity. J Mol Pharmacol. 79:631–38.
  • Seike M, Furuya K, Omura M, Hamada- Watanabe K, Matsushita A, Ohtsu H. 2010. Histamine H4 receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge. Allergy. 65:319–26.
  • Shin N, Covington M, Bian D, Zhuo J, Bowman K, Li Y, Soloviev M, Qian D-Q, Feldman P, Leffet L, et al. 2012. INCB38579, a novel potent histamine h4 receptor small molecule antagonist with anti-inflammatoryand anti-pruritic functions. Eur J Pharmacol. 675:47–56.
  • Somma T, Cinci L, Formicola G, Pini A, Thurmond R, Ennis M, Bani D, Masini E. 2013. A selective antagonist of histamine H4 receptors prevents antigen induced airway inflammation and broncoconstriction in guinea pigs: involvement of lipocortin- I. Br J Pharmacol. 170:200–13.
  • Strakhova MI, Cuff CA, Manelli AM, Carr TL, Witte DG, Baranowski JL, Vortherms TA, Miller TR, Rundell L, McPherson MJ, et al. 2009. In vitro and in vivo characterization of A-940894: a potent histamine h4 receptor antagonist with anti-inflammatory properties. Br J Pharmacol. 157(1):44–54.
  • Suwa E, Yamaura K, Oda M, Namiki T, Ueno K. 2011. Histamine H4 receptor antagonist reduces dermal inflammation and pruritus in a hapten- induced experimental model. Eur J Pharmacol. 667:383–88.
  • Thurmond RL. 2015. The histamine H4 receptor: from orphan to the clinic. Front Pharmacol. 6:1–11.
  • Thurmond RL, Chen B, Dunford PJ, Greenspan AJ, Karlsson L, La D, Ward P, Xu XL. 2014a. Clinical and preclinical characterization of the histamine H4 receptor antagonist JNJ-39758979. J Pharmacol Exp Ther. 667:383–88.
  • Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung WP, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, et al. 2004. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther. 309:404–13.
  • Thurmond RL, Kazerouni K, Chaplan SR, Greenspan AJ. 2014b. Peripheral neuronal mechanism of itch: histamine and itch. Chap. 10. In: Carstens E, Akiyama T, editors. Itch: mechanisms and treatment. Boca Raton (FL): CRC Press. p. 143–92.
  • Venable JD, Cai H, Chai W, Dvorak CA, Grice CA, Jablonowski JA, Shah CR, Kwok AK, Ly KS, Pio B, et al. 2005. Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine H4 antagonists. J Med Chem. 48:8289–98.
  • Yan S, Ci X, Chen N, Chen C, Li X, Chu X, Li J, Deng X. 2011. Anti- inflammatory effects of ivermectin in mouse model of allergic asthma. Inflamm Res. 60(6):589–96.
  • Yuan Y, Yang B, Ye Z, Zhang M, Yang X, Xin C, Lin M, Huang P. 2013. Sceptridium ternatum exerts antiasthmatic effects by regulating Th1/Th2 balance and the expression levels of leukotriene receptors in a mouse asthma model. J Ethnopharmacol. 149(3):701–06.
  • Yuk JE, Lee MY, Kwon OK, Cai XF, Jang HY, Oh SR, Lee HK, Ahn KS. 2011. Effects of astalbic acid on airway hyperresponsiveness and inflammation in a mouse model of allergic asthma. Int J Immunopharmacol. 11:266–73.
  • Yun Kim H, Jee H, Yeom J-H, Jeong HJ, Kim HM. 2019. The ameliorative effect of AST2017-01 in an ovalbumin- induced allergic rhinitis model. Inflammation Res. doi:10.1007/s00011-019-01226-y
  • Zampeli E, Tiligada E. 2009. The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol. 157:24–33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.